SCHEMBL1132285

SCHEMBL1132285

CC(CCl)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9195742 1.00
SCHEMBL10454016 1.00
Hydrochloric Acid SCHEMBL4420756 0.97
SCHEMBL11641033 0.92 GABRR1 (0.42)
Dimethylamine SCHEMBL28736884 0.92 GABRR1 (0.42)
R-Chloropropionate SCHEMBL11641041 0.85 CYP1A2 (0.54)
SCHEMBL11469651 0.82 GABRR1 (0.35)
Pyridine SCHEMBL28828227 0.82 TBXAS1 (0.41)
SCHEMBL1132140 0.78 NAALAD2 (0.45)
SCHEMBL11639515 0.78 ALDH1A1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 652 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119775506-A Use of polymers for producing compositions for bonding membrane structures 北京大学 2025-04-08 CN claimed
CN-118994049-B Synthesis method of ceftazidime side chain ethyl ester 山东金城医药化工有限公司 2025-02-14 CN claimed
CN-118994049-A Synthesis method of ceftazidime side chain ethyl ester 山东金城医药化工有限公司 2024-11-22 CN claimed
EP-3169403-B9 ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES PROTAGONIST THERAPEUTICS INC (US) 2024-07-03 EP claimed
US-20240199700-A1 ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES PROTAGONIST THERAPEUTICS INC (US) 2024-06-20 US claimed
EP-4378536-A2 ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES Protagonist Therapeutics, Inc. (US) 2024-06-05 EP claimed
EP-3169403-B1 ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES PROTAGONIST THERAPEUTICS INC (US) 2024-02-14 EP claimed
CN-117069603-A Synthesis method of 3-aminoisobutyric acid 福建清研生物科技有限公司 2023-11-17 CN claimed
CN-218860379-U 2-methyl chloropropionate esterification wastewater raw material recovery system 内蒙古恒泰生物科技有限公司 2023-04-14 CN claimed
CN-110922547-B Double-anchoring type block copolymer and preparation method and application thereof 安徽大学 2023-02-28 CN claimed
CN-101481432-A Atom transfer radical polymerization method for ion liquid microemulsion UNIV SOOCHOW (CN) 2009-07-15 CN claimed
CN-101434529-A Chemical synthesis formula and process of veratone GUANGHUI WANG (CN) 2009-05-20 CN claimed
CN-100436399-C Method of preparing (S)-(-)-2-chloropropionate and (R)-(+)-2-chloro propionic acid UNIV ZHEJIANG TECHNOLOGY (CN) 2008-11-26 CN claimed
CN-101220105-A Method for preparing high molecular compound UNIV WUHAN (CN) 2008-07-16 CN claimed
CN-100383104-C Synthesis and purification process of (2-methyl)-3-chloropropionyl chloride SHANGHAI HUAYI ACRYLIC ACID CO (CN) 2008-04-23 CN claimed
CN-101139412-A Low-molecular weight distributed polyacrylonitile and method for making same UNIV DONGHUA (CN) 2008-03-12 CN claimed
CN-1868997-A Method of preparing (S)-(-)-2-chloropropionate and (R)-(+)-2-chloro propionic acid UNIV ZHEJIANG TECHNOLOGY (CN) 2006-11-29 CN claimed
CN-1740132-A Synthesis and purification process of (2-methyl)-3-chloropropionyl chloride SHANGHAI HUAYI ACRYLIC ACID CO (CN) 2006-03-01 CN claimed
CN-1696105-A Method for preparing (2-methyl)3-ester chloropropionic acid HUAYI ACRYLIC ACID CO LTD SHAN (CN) 2005-11-16 CN claimed
CN-88101671-A Antistatic and conduct electricity polymkeric substance and moulding material 1988-10-19 CN claimed